Skip to main content
Retour
Watch Compare

PMV Pharmaceuticals, Inc.

Qualité des données : 83%
PMVP
NASDAQ Manufacturing Chemicals
1,42 €
▲ 0,05 € (3,28%)
6 months return
—
Momentum
Neutral
ROE
-59,43%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-59,43%
En dessous de la moyenne du secteur (-54,47%)
ROIC-51,83%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio10,76
Interest Coverage-13,60

Valorisation

P/E Ratio
-0,91 TTM
-1,28 NTM
Au-dessus de la moyenne du secteur (-1,50)
P/B Ratio0,58
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -73,61 M

Price History

Tendances Financières

Objectif de Cours des Analystes

4 analystes
Buy
+235.7%
upside to target
Actuel
1,42 €
Consensus Target
4,75 €
4,00 €
Bas
6,00 €
Haut
Prévisions
P/E Prévisionnel
-1,28
BPA Prévisionnel
-1,10 €
CA Est.
2,97 M

Surprises de Résultats

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -0,39 € · Rev Est: 0,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -0,34 € -0,41 € -0,40 € -0,34 € — —
Estimate -0,38 € -0,39 € -0,40 € -0,40 € -0,39 € -0,42 €
Surprise +11,30% -6,49% +0,62% +13,92% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -59,43% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -77,74 M
ROE -59,43% ROA -54,23%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -73,61 M
ROIC -51,83% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 10,76
Debt / Equity N/A Current Ratio 10,76
Interest Coverage -13,60 Asset Turnover N/A
Working Capital 120,15 M Tangible Book Value 121,00 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,91 · EV/EBITDA: N/A
P/E Ratio -0,91 Forward P/E -1,28
P/B Ratio 0,58 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 23,77 Fwd Earnings Yield N/A
FCF Yield -104,17%
Market Cap 70,66 M Enterprise Value 34,32 M

Per Share

EPS: -1,48 · FCF/Share: -1,38
EPS (Diluted TTM) -1,48 Revenue / Share N/A
FCF / Share -1,38 OCF / Share -1,38
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 94,68% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 94,68%
SBC-Adj. FCF -80,78 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -77,74 M -58,71 M -68,96 M -73,32 M -57,85 M
EPS (Diluted) -1,48 -1,14 -1,44 -1,61 —
Gross Profit — — — — —
Operating Income -86,21 M -85,45 M -80,13 M -77,04 M -58,29 M
EBITDA — — — — —
R&D Expenses 69,88 M 58,53 M 55,89 M 51,99 M 36,49 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 6,34 M 10,66 M 11,17 M 3,63 M 449 000,0
Income Tax -2,17 M -16,10 M 2 000,0 -9 000,0 23 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 116,56 M 191,29 M 252,15 M 270,31 M 331,57 M
Total Liabilities 11,85 M 15,21 M 26,46 M 24,28 M 23,01 M
Shareholders' Equity 104,71 M 176,08 M 225,69 M 246,03 M 308,56 M
Total Debt — — — — —
Cash & Equivalents 37,98 M 40,88 M 37,71 M 108,30 M 172,47 M
Current Assets 115,23 M 175,66 M 207,41 M 247,01 M 301,29 M
Current Liabilities 11,42 M 14,37 M 14,03 M 10,83 M 12,22 M

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -0,9 -1,5
P/B 0,6 1,6
ROE % -59,4 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock
BRUSX BRUSX
0,46% weight
MISGX MISGX
0,41% weight
MSGAX MSGAX
0,41% weight
MSGRX MSGRX
0,41% weight
MSGCX MSGCX
0,41% weight
MSGGX MSGGX
0,41% weight
BRSIX BRSIX
0,06% weight
BDSCX BDSCX
0,01% weight
BDSKX BDSKX
0,01% weight
BDSAX BDSAX
0,01% weight